Calidi Biotherapeutics Provides Corporate Update and Key Value Drivers for 2026
Company intends to file an IND in Q4 2026 for its first RedTail lead candidate, CLD-401, a systemically delivered and...
Cancer
BriaCell Patients’ Images Show Regression and Resolution of Metastasized Tumors and Immune Activation
Images below confirm clinical responses seen in patients with metastatic orbital (eye), temporal (brain), liver, and spine lesions No Bria-IMT™...
Radiopharm Theranostics Reports Half-Year Financial Results and Business Updates
Interim results from Phase 2b clinical trial of RAD 101 showed 92% of evaluable participants met the primary endpoint of...
AIM ImmunoTech Announces Changes to Key Dates and Terms Related to Announced Rights Offering
OCALA, Fla., Jan. 27, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) – AIM ImmunoTech Inc. (“AIM” or the...
Izotropic Provides Corporate Update & Announces Non-Brokered Private Placement
Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - January 28, 2026) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3)...
Patient Safety Movement Foundation Announces Dr. Jill Biden as Keynote Speaker at the 12th Annual World Patient Safety, Science & Technology Summit
DANA POINT, CA AND IRVINE, CA / ACCESS Newswire / January 27, 2026 / The Patient Safety Movement Foundation (PSMF)...
Center for Innovation & Value Research Appoints Marc Boutin as President & Chief Executive Officer
ALEXANDRIA, Va., Jan. 27, 2026 /PRNewswire/ -- The Center for Innovation & Value Research (Center) today announced the appointment of Marc...
Hackensack Meridian Health and Lumeris Expand Value-Based Partnership to Include Traditional Medicare Through MSSP ACO
Collaboration builds on high-performing Clinically Integrated Network for Commercial and Medicare Advantage to improve outcomes and care coordination for New...
AI Medical Imaging Revolution: Software-Native Tech Disrupts $45B Market
ISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD.VANCOUVER, BC, Jan. 27, 2026 /PRNewswire/ -- USANewsGroup.com News Commentary – The global medical imaging market...
Orchestra Life Sciences Expands into Europe to Support Radiopharmaceutical Execution, Appoints Vinod Ramnandanlal as President and Managing Director
The expansion builds on existing client engagements and growing demand for regional execution supportPHILADELPHIA, Jan. 27, 2026 /PRNewswire/ -- Orchestra...
CNS Pharmaceuticals Issues Letter to Shareholders
Newly Appointed President & Chief Executive Officer, Rami Levin, Discusses Plans for a New Era at CNS PharmaceuticalsStrategic Focus, Pipeline...
Myriad Advances MRD Commercialization Timeline, Bolstered by New Study Data
Precise MRD™ to transition from research-use-only into a limited clinical launch in March 2026SALT LAKE CITY, Jan. 27, 2026 (GLOBE...
Ernexa Therapeutics Selected as One of Only Ten Global Companies for Prestigious JETRO Japan Entry Acceleration Program
CAMBRIDGE, Mass., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for...
Propanc Biopharma Accelerates IP Momentum: Files Fourth Provisional Patent Application in Just Two Months – Strengthening Global Protection for Breakthrough Proenzyme Formulations
Key Milestone Builds Toward Doubling Patent Portfolio to Over 200 Worldwide – Positioning Propanc as a Long-Term Leader in Metastatic...
Imviva Biotech Receives FDA Orphan Drug Designation for CTD402 for the Treatment of T-Cell Leukemia and Lymphoma
BOSTON, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Imviva Biotech, a clinical-stage biotechnology company developing next-generation allogeneic CAR-T cell therapies, today...
CytoDyn Announces Funding and Initiation of Expanded Access Program for Patients with Triple-negative Breast Cancer
VANCOUVER, Washington, Jan. 27, 2026 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a clinical-stage oncology company...
Lisata Therapeutics Announces Mutual Termination of License Agreement with Qilu Pharmaceutical for Certepetide
Lisata regains full development rights to certepetide in the Greater China RegionBASKING RIDGE, N.J., Jan. 27, 2026 (GLOBE NEWSWIRE) --...
CancerIQ and Azra AI Partner to Support Growing Lung Cancer Screening Programs
Partnership aligns risk-based patient engagement, LDCT screening, and AI-powered imaging follow-up as lung programs scaleCHICAGO and NASHVILLE, Tenn., Jan. 26,...
Phio Pharmaceuticals Announces Participation in Third Annual DealFlow Discovery Conference
Phio's Presentation to take place on Wednesday January 28, 2026 at 9 AM ETKing of Prussia, Pennsylvania--(Newsfile Corp. - January...
Moderna to Report Fourth Quarter 2025 Financial Results on Friday, February 13, 2026
CAMBRIDGE, MA / ACCESS Newswire / January 26, 2026 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a...